Robert Fildes Ph.D., Director at LA JOLLA PHARMACEUTICAL CO (LJPC), sold 16,612 shares at $0.05 ($831) on 2009-02-26, disclosed to the SEC on 2009-02-27.
Open-market sale of $831 LJPC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.